Mutations in Troponin that cause HCM, DCM AND RCM: What can we learn about thin filament function?

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 5, 2010, Pages 882-892

  Willott, Ruth H ^a   Gomes, Aldrin V ^b   Chang, Audrey N ^c   Parvatiyar, Michelle S ^a   Pinto, Jose Renato ^a   Potter, James D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

ATPase; Calcium sensitivity; Cardiomyopathy; Mutations; Troponin

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM ION; TROPONIN; TROPONIN I; TROPONIN T;

CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CONGESTIVE CARDIOMYOPATHY; ELECTROCARDIOGRAM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE MUTATION; GENETIC ASSOCIATION; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CONTRACTILE FORCE; HEART VENTRICLE HYPERTROPHY; HUMAN; MUSCLE CONTRACTION; MUTATIONAL ANALYSIS; MYOFILAMENT; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; RESTRICTIVE CARDIOMYOPATHY; REVIEW; THIN FILAMENT;

ANIMALS; CALCIUM; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, RESTRICTIVE; HUMANS; MUTATION; TROPONIN;

EID: 77951621530     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.10.031     Document Type: Review

References (185)

1. Holmes K.C. Muscle proteins-their actions and interactions. Curr Opin Struct Biol 1996, 6:781-789.
2. Lymn R.W., Taylor E.W. Mechanism of adenosine triphosphate hydrolysis by actomyosin. Biochemistry 1971, 10(25):4617-4624.
3. Solaro R.J., Rarick H.M. Troponin and tropomyosin. Proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res 1998, 83:471-480.
4. Zot A.S., Potter J.D. Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu Rev Biophys Biophys Chem 1987, 16:535-559.
5. Farah C.S., Reinach F.C. The troponin complex and regulation of muscle contraction. FASEB J 1995, 9(9):755-767.
6. Greaser M.L., Gergely J. Reconstitution of troponin activity from three protein components. J Biol Chem 1971, 246(13):4226-4233.
7. Greaser M.L., Gergely J. Purification and properties of the components from troponin. J Biol Chem 1973, 248:2125-2133.
8. 2+ regulation of muscle contraction. Biochemistry 1974, 13:2697-2703.
9. Ashley C.C., Mulligan I.P., Lea T.J. Ca2+ and activation mechanisms in skeletal muscle. Q Rev Biophys 1991 Feb, 24(1):1-73.
10. Takeda S., Yamashita A., Maeda K., Maeda Y. Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature 2003, 424(6944):35-41.
11. 2+-regulated structural changes in troponin. Proc Natl Acad Sci U S A 2005 Apr 5, 102(14):5038-5043.
12. Craig R., Lehman W. Crossbridge and tropomyosin positions observed in native, interacting thick and thin filaments. J Mol Biol 2001, 311:1027-1036.
13. Solaro R.J., Van Eyk J. Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol 1996, 28:217-230.
14. Squire J.M., Morris E.P. A new look at thin filament regulation in vertebrate skeletal muscle. FASEB J 1998, 12:761-771.
15. Vibert P., Craig R., Lehman W. Steric-model for activation of muscle thin filaments. J Mol Biol 1997, 266:8-14.
16. Xu C., Craig R., Tobacman L., Horowitz R., Lehman W. Tropomyosin positions in regulated thin filaments revealed by cryoelectron microscopy. Biophys J 1999, 77:985-992.
17. Lehman W., Rosol M., Tobacman L.S., Craig R. Troponin organization on relaxed and activated thin filaments revealed by electron microscopy and three-dimensional reconstruction. J Mol Biol 2001, 307:739-744.
18. 2+-induced switching of troponin and tropomyosin on actin filaments as revealed by electron cryo-microscopy. J Mol Biol 2001, 308:241-261.
19. Pirani A., Vinogradova M.V., Curmi P.M.G., King W.A., Fletterick R.J., Craig R., et al. An atomic model of the thin filament in the relaxed and Ca2+-activated states. J Mol Biol 2006, 357:707-717.
20. Blumenschein T.M.A., Stone D.B., Fletterick R.J., Mendelson R.A., Sykes B.D. Calcium-dependent changes in the flexibility of the regulatory domain of troponin C in the troponin complex. J Biol Chem 2005, 280(23):21924-21932.
21. Hoffmann R.M.B., Blumenschein T.M.A., Sykes B.D. An interplay between protein disorder and structure confers the Ca2+ regulation of striated muscle. J Mol Biol 2006, 361:625-633.
22. Sun Y.B., Brandmeier B., Irving M. Structural changes in troponin in response to Ca2+ and myosin binding to thin filaments during activation of skeletal muscle. Proc Natl Acad Sci U S A 2006 Nov 21, 103(47):17771-17776.
23. McKillop D.F.A., Geeves M.A. Regulation of the interaction between actin and myosin subfragment 1: evidence for three states of the thin filament. Biophys J 1993, 65:693-701.
24. Brenner B. Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction. Proc Natl Acad Sci U S A 1988 May, 85(9):3265-3269.
25. Hinkle A., Goranson A., Butters C.A., Tobacman Roles for the troponin tail domain in thin filament assembly and regulation. A deletional study of cardiac troponin T. J Biol Chem 1999, 274:7157-7164.
26. Lehman W., Hatch V., Korman V., Rosol M., Thomas L., Maytum R., et al. Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments. J Mol Biol 2000, 302:593-606.
27. Lehrer S.S., Geeves M.A. The muscle thin filament as a classical cooperative/allosteric regulatory system. J Mol Biol 1998, 277:1081-1089.
28. Tobacman L.S., Nihli M., Butters C., Heller M., Hatch V., Craig R., et al. The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity. J Biol Chem 2002, 277(31):27636-27642.
29. Geeves M.A., Lehrer S.S. Dynamics of the muscle thin filament regulatory switch: the size of the cooperative unit. Biophys J 1994, 67:273-282.
30. Maytum R., Lehrer S.S., Geeves M.A. Cooperativity and switching within the three-state model of muscle regulation. Biochemistry 1999, 38:1102-1110.
31. Schaertl S., Lehrer S.S., Geeves M.A. Separation and characterization of the two functional regions of troponin involved in muscle thin filament regulation. Biochemistry 1995, 34:15890-15894.
32. Bonne G., Carrier L., Richard P., Hainque B., Schwartz K. Familial hypertrophic cardiomyopathy. From mutations to funcational defects. Circ Res 1998, 83:580-593.
33. Maron B.J., Roberts W.C., McAllister H.A., Rosing D.R., Epstein S.E. Sudden death in young athletes. Circulation 1980, 62(2):218-229.
34. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1957, 20:1-8.
35. Franz W.M., Müller O.J., Katus H.A. Cardiomyopathies: from genetics to the prospect of treatment. Lancet 2001, 358:1627-1637.
36. McKenna W.J., Camm J.A. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation 1989, 80:1489-1491.
37. Oakley C. Aetiology, diagnosis, investigation, and management of the cardiomyopathies. Br Med J 1997, 315:1520-1524.
38. Vikstrom K.L., Leinwand L.A. Contractile proteins and heart disease. Curr Opin Cell Biol 1996, 8:97-105.
39. Geisterfer-Lowrance A.A., Kass S., Tanigawa G., Vosberg H.P., McKenna W., Seidman C.E., et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 1990, 62:999-1006.
40. Poetter K., Jiang H., Hassanzadeh S., Master S.R., Chang A., Dalakas M.C., et al. Mutations in either the essential or the regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1996, 13:63-69.
41. Bonne G., Carrier L., Bercovici J., Cruaud C., Richard P., Hainque B., et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995, 11:438-440.
42. Watkins H., Conner D., Thierfelder L., Jarcho J.A., MacRae C., McKenna W.J., et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995, 11:434-437.
43. Manatsu S., Takahashi M., Sakamoto T., Hiroe M., Marumo F., Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 1999, 262:411-417.
44. Mogensen J., Klausen I.C., Pedersen A.K., Egeblad H., Bross P., Kruse T., et al. α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. Eur J Clin Invest 1999, 103:R39-R43.
45. Watkins H., McKenna W., Thierfelder L., Suk J., Anan R., O'Donoghue A., et al. Mutations in the genes for cardiac troponin t and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995, 332:1058-1064.
46. Thierfelder L., Watkins H., MacRae C., Lamas R., McKenna W., Vosberg H.P., et al. α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994, 77:701-712.
47. Ho C.Y., Lever H.M., DeSanctis R., Farver C.F., Seidman J.G., Seidman C.E. Homozygous mutation in cardiac troponin T. Implications for hypertrophic cardiomyopathy. Circulation 2000, 102:1950-1955.
48. Moolman J.C., Corfield V.A., Posen B., Ngumbela K., Seidman C., Brink P.A., et al. Sudden death due to troponin T mutations. J Am Coll Cardiol 1997 Mar 1, 29(3):549-555.
49. Nakajima-Taniguichi C., Matsui H., Fujio Y., Nagata S., Kishimoto T., Yamauchi-Takihara K. novel missense mutation in cardiac troponin T gene found in japanese patient with hypertrophic cardiomyopathy. J Mol Cell Cardiol 1997, 29:839-843.
50. Kimura A., Harada H., Park J.E., Nishi H., Satoh M., Takahashi M., et al. Mutations in the Troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997, 16:379-382.
51. Blair E., Redwood C., Ashrafian H., Oliveira M., Broxholme J., Kerr B., et al. Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001, 10(11):1215-1220.
52. Geier C., Perrot A., Özcelik C., Binner P., Counsell D., Hoffmann K., et al. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 2003, 107:1390-1395.
53. Varnava A.M., Elliott P.M., Baboonian C., Davison F., Davies M.J., McKenna W.J. Hypertrophic cardiomyopathy. histopathological features of sudden death in cardiac troponin T disease. Circulation 2001, 104:1380-1384.
54. Schönberger J., Seidman C.E. Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am J Hum Genet 2001, 69:249-260.
55. Seidman J.G., Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001, 104:557-567.
56. Michels V.V., Moll P.P., Miller F.A., Tajik J., Chu J.S., Driscoll D.J., et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992, 326(2):77-82.
57. Grünig E., Tasman J.A., Kücherer H., Franz W., Kübler W., Katus H.A. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998, 31(1):186-194.
58. Keeling P.J., Gang Y., Smith G., Seo H., Bent S.E., Murday V., et al. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J 1995, 73:417-421.
59. Mestroni L., Rocco C., Gregori D., Sinagra G., Di Lenarda A., Miocic S., et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol 1999, 34(1):181-190.
60. Olson T.M., Michels V.V., Thibodeau S.N., Tai Y.S., Keating M.T. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998, 280:750-752.
61. Kamisago M., Sharma S.D., DePalma S.R., Solomon S., Sharma P., McDonough B., et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000 Dec 7, 343(23):1688-1696.
62. Shimizu M., Ino H., Yasuda T., Fujino N., Uchiyama K., Mabuchi T., et al. Gene mutations in adult Japanese patients with dilated cardiomyopathy. Circ. J. 2005, 69:150-153.
63. Gerull B., Gramlich M., Atherton J., McNabb M., Trombitas K., Sasse-Klaassen S., et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002 Feb, 30(2):201-204.
64. Olson T.M., Kishimoto N.Y., Whitby F.G., Michels V.V. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 2001 Apr, 33(4):723-732.
65. Li D., Czernuszewicz G.Z., Gonzalez O., Tapscott T., Karibe A., Durand J.B., et al. Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation 2001 Oct 30, 104(18):2188-2193.
66. Mogensen J., Murphy R.T., Shaw T., Bahl A., Redwood C., Watkins H., et al. Severe disease expression of cardiac troponin c and t mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004, 44:2033-2040.
67. Ammash N.M., Seward J.B., Bailey K.R., Edwards W.D., Tajik A.J. Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation 2000 May 30, 101(21):2490-2496.
68. Angelini A., Calzolari V., Thiene G., Boffa G.M., Valente M., Daliento L., et al. Morphologic spectrum of primary restrictive cardiomyopathy. Am J Cardiol 1997 Oct 15, 80(8):1046-1050.
69. Hughes S., McKenna W.J. New insights into the pathology of inherited cardiomyopathy. Heart 2005, 91:257-264.
70. Kushwaha S., Fallon J.T., Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997, 336:267-276.
71. Schwartz M.L., Colan S.D. Familial restrictive cardiomyopathy with skeletal abnormalities. Am J Cardiol 2003, 92:636-639.
72. Mogensen J., Kubo T., Duque M., Uribe W., Shaw A., Murphy R., et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. Eur J Clin Invest 2003, 111:209-216.
73. Chein K.R., Olson E.N. Converging pathways and principles in heart development. Cell 2002, 110:153-162.
74. Zhang J., Kumar A., Stalker H.J., Virdi G., Ferrans V.J., Horiba K., et al. Clinical and molecular studies of a large family with desmin-associated restrictive cardiomyopathy. Clin Genet 2001 Apr, 59(4):248-256.
75. Kaski J.P., Syrris P., Burch M., Tome-Esteban M.T., Fenton M., Christiansen M., et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. Heart 2008 Nov, 94(11):1478-1484.
76. Thierfelder L., MacRae C., Watkins H., Tomfohrde J., Williams M., McKenna W., et al. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci U S A 1993, 90(13):6270-6274.
77. Thierfelder L., Watkins H., MacRae C., Lamas R., McKenna W., Vosberg H.P., et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994 Jun 3, 77(5):701-712.
78. Hoffmann B., Schmidt-Traub H., Perrot A., Osterziel K.J., Gessner R. First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum Mutat 2001 Jun, 17(6):524.
79. Mogensen J., Murphy R.T., Kubo T., Bahl A., Moon J.C., Klausen I.C., et al. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004 Dec 21, 44(12):2315-2325.
80. Tikunova S.B., Rall J.A., Davis J.P. Effect of hydrophobic residue substitutions with glutamine on Ca(2+) binding and exchange with the N-domain of troponin C. Biochemistry 2002 May 28, 41(21):6697-6705.
81. Tikunova S.B., Davis J.P. Designing calcium-sensitizing mutations in the regulatory domain of cardiac troponin C. J Biol Chem 2004 Aug 20, 279(34):35341-35352.
82. Gillies C., Raye J., Vasan U., Hart W.E., Goldblatt P.J. Nemaline (rod) myopathy: a possible cause of rapidly fatal infantile hypotonia. Arch Pathol Lab Med 1979 Jan, 103(1):1-5.
83. Pearlstone J.R., McCubbin W.D., Kay C.M., Sykes B.D., Smillie L.B. Spectroscopic analysis of a methionine-48 to tyrosine mutant of chicken troponin C. Biochemistry 1992, 31(40):9703-9708.
84. da Silva A.C., de Araujo A.H., Herzberg O., Moult J., Sorenson M., Reinach F.C. Troponin-C mutants with increased calcium affinity. Eur J Biochem 1993, 213(1):599-604.
85. Smith L., Greenfield N.J., Hitchcock-DeGregori S.E. Mutations in the N- and D-helices of the N-domain of troponin C affect the C-domain and regulatory function. Biophys J 1999, 76(1 Pt 1):400-408.
86. Chandra M., McCubbin W.D., Oikawa K., Kay C.M., Smillie L.B. Ca2+, Mg2+, and troponin I inhibitory peptide binding to a Phe-154 to Trp mutant of chicken skeletal muscle troponin C. Biochemistry 1994, 33(10):2961-2969.
87. Baryshnikova O.K., Li M.X., Sykes B.D. Modulation of cardiac troponin C function by the cardiac-specific N-terminus of troponin I: influence of PKA phosphorylation and involvement in cardiomyopathies. J Mol Biol 2008 Jan 18, 375(3):735-751.
88. Lim C.C., Yang H., Yang M., Wang C.K., Shi J., Berg E.A., et al. A novel mutant cardiac troponin C disrupts molecular motions critical for calcium binding affinity and cardiomyocyte contractility. Biophys J 2008 May 1, 94(9):3577-3589.
89. Venkatraman G., Harada K., Gomes A.V., Kerrick G.W., Potter J.D. Different functional properties of troponin T mutants that cause dilated cardiomyopathy. J Biol Chem 2003, 278:41670-41678.
90. Dweck D., Hus N., Potter J.D. Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes. J Biol Chem 2008 Nov 28, 283(48):33119-33128.
91. Landstrom A.P., Parvatiyar M.S., Pinto J.R., Marquardt M.L., Bos J.M., Tester D.J., et al. Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C. J Mol Cell Cardiol 2008 Aug, 45(2):281-288.
92. Pinto J.R., Parvatiyar M.S., Jones M.A., Liang J., Ackerman M.J., Potter J.D. A functional and structural study of troponin C mutations related to hypertrophic cardiomyopathy. J Biol Chem 2009 Jul 10, 284(28):19090-19100.
93. Szczesna D., Zhang R., Zhao J., Jones M., Guzman G., Potter J.D. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. J Biol Chem 2000 Jan 7, 275(1):624-630.
94. 2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy. J Biol Chem 1999 Mar 26, 274(13):8806-8812.
95. Miller T., Szczesna D., Housmans P.R., Zhao J., de Freitas F., Gomes A.V., et al. Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation. J Biol Chem 2001 Feb 9, 276(6):3743-3755.
96. Lang R., Gomes A.V., Zhao J., Housmans P.R., Miller T., Potter J.D. Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy. J Biol Chem 2002 Apr 5, 277(14):11670-11678.
97. Elliott K., Watkins H., Redwood C.S. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem 2000, 275:22069-22074.
98. Gomes A.V., Liang J., Potter J.D. Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development. J Biol Chem 2005 September 2, 280(35):30909-30915.
99. 2+-desensitizing effect of a deletion mutation ΔK210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proceedings of the National Academy of Sciences. USA 2002, 99(2):913-918.
100. Robinson P., Mirza M., Knott A., Abdulrazzak H., Willott R., Marston S., et al. Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J Biol Chem 2002, 277:40710-40716.
101. Venkatraman G., Gomes A.V., Kerrick W.G.L., Potter J.D. Characterization of the troponin T dilated cardiomyopathy mutations in the fetal troponin isoform. J Biol Chem 2005, 280:17584-17592.
102. Dweck D., Gomes A.V., Potter J.D. Functional effects of human cardiac troponin C mutations linked to familial and dilated cardiomyopathies. Biophys J 2005, 88. 1551-Pos.
103. 2+ regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein. Circ Res 2000, 86:1146-1152.
104. Perry S.V., Troponin I. Inhibitor or facilitator. Mol Cell Biochem 1999, 190:9-32.
105. Pinto J.R., Parvatiyar M.S., Jones M.A., Liang J., Potter J.D. A troponin T mutation that causes infantile restrictive cardiomyopathy increases Ca2+ sensitivity of force development and impairs the inhibitory properties of troponin. J Biol Chem 2008 Jan 25, 283(4):2156-2166.
106. Sweeney H.L., Feng H.S., Yang Z., Watkins H. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Natl Acad Sci U S A 1998 Nov 24, 95(24):14406-14410.
107. Morimoto S., Yanaga F., Minakami R., Ohtsuki I. Ca2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. Am J Physiol 1998 Jul, 275(1 Pt 1):C200-207.
108. Nakaura H., Yanaga F., Ohtsuki I., Morimoto S. Effects of missense mutations Phe110Ile and Glu244Asp in human cardiac troponin T on force generation in skinned cardiac muscle fibers. J Biochem 1999 Sep, 126(3):457-460.
109. Nakaura H., Morimoto S., Yanaga F., Nakata M., Nishi H., Imaizumi T., et al. Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy. Am J Physiol 1999 Aug, 277(2 Pt 1):C225-232.
110. Harada K., Potter J.D. Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction. J Biol Chem 2004 Apr 9, 279(15):14488-14495.
111. Hernandez O., Szczesna-Cordary D., Knollmann B.C., Miller T., Bell M., Zhao J., et al. F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers. J Biol Chem 2005 Nov 4, 280(44):37183-37194.
112. Montgomery D.E., Tardiff J.C., Chandra M. Cardiac troponin T mutations: correlation between the type of mutation and the nature of the myofilament dysfunction in transgenic mice. Journal of Physiology 2001, 536(2):583-592.
113. 2+ activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T. Am J Physiol Heart Circ Physiol 2001 Feb, 280(2):H705-H713.
114. Venkatraman G., Gomes A.V., Kerrick W.G., Potter J.D. Characterization of troponin T dilated cardiomyopathy mutations in the fetal troponin isoform. J Biol Chem 2005 May 6, 280(18):17584-17592.
115. Mirza M., Marston S., Willott R., Ashley C., Mogensen J., McKenna W., et al. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype. J Biol Chem 2005, 280:28498-28506.
116. Jideama N.M., Noland T.A., Raynor R.L., Blobe G.C., Fabbro D., Kazanietz M.G., et al. Phosphorylation specificities of protein kinase c isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J Biol Chem 1996 September 20, 271(38):23277-23283. 1996.
117. Gordon A.M., Homsher E., Regnier M. Regulation of contraction in striated muscle. Physiol Rev 2000 Apr, 80(2):853-924.
118. Guth K., Potter J.D. Effect of rigor and cycling cross-bridges on the structure of troponin C and on the Ca2+ affinity of the Ca2+-specific regulatory sites in skinned rabbit psoas fibers. J Biol Chem 1987, 262(28):13627-13635.
119. Zot A.S., Potter J.D. Reciprocal coupling between troponin C and myosin crossbridge attachment. Biochemistry 1989, 28(16):6751-6756.
120. Pinto J.R., Veltri T., Sorenson M.M. Modulation of troponin C affinity for the thin filament by different cross-bridge states in skinned skeletal muscle fibers. Pflugers Arch 2008 Sep, 456(6):1177-1187.
121. Martyn D.A., Regnier M., Xu D., Gordon A.M. Ca2+-and cross-bridge-dependent changes in N- and C-terminal structure of troponin C in rat cardiac muscle. Biophys J 2001 Jan, 80(1):360-370.
122. Li H.C., Fajer P.G. Structural coupling of troponin C and actomyosin in muscle fibers. Biochemistry 1998 May 12, 37(19):6628-6635.
123. Lin D., Bobkova A., Homsher E., Tobacman L.S. Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. J Clin Invest 1996 Jun 15, 97(12):2842-2848.
124. Redwood C., Lohmann K., Bing W., Esposito G.M., Elliott K., Abdulrazzak H., et al. Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein. Circ Res 2000, 86(11):1146-1152.
125. Tobacman L.S., Lin D., Butters C., Landis C., Back N., Pavlov D., et al. Functional consequences of troponin T mutations found in hypertrophic cardiomyopathy. J Biol Chem 1999, 274(40):28363-28370.
126. Homsher E., Lee D.M., Morris C., Pavlov D., Tobacman L.S. Regulation of force and unloaded sliding speed in single thin filaments: effects of regulatory proteins and calcium. J Physiol 2000 Apr 1, 524(Pt 1):233-243.
127. Palm T., Graboski S., Hitchcock-DeGregori S.E., Greenfield N.J. Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region. Biophys J 2001 Nov, 81(5):2827-2837.
128. Chandra M., Tschirgi M.L., Tardiff J.C. Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation. Am J Physiol Heart Circ Physiol 2005 November 1, 289(5):H2112-2119.
129. Javadpour M.M., Tardiff J.C., Pinz I., Ingwall J.S. Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. J Clin Invest 2003 Sep, 112(5):768-775.
130. He H., Javadpour M.M., Latif F., Tardiff J.C., Ingwall J.S. R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts. Biophys J 2007 Sep 1, 93(5):1834-1844.
131. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006, 7(8):589-600.
132. Du C.K., Morimoto S., Nishii K., Minakami R., Ohta M., Tadano N., et al. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res 2007 Jul 20, 101(2):185-194.
133. Ahmad F., Banerjee S.K., Lage M.L., Huang X.N., Smith S.H., Saba S., et al. The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy. PLoS ONE 2008, 3(7):e2642.
134. Wen Y., Pinto J.R., Gomes A.V., Xu Y., Wang Y., Wang Y., et al. Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice. J Biol Chem 2008 Jul 18, 283(29):20484-20494.
135. Wen Y., Xu Y., Wang Y., Pinto J.R., Potter J.D., Kerrick W.G. Functional effects of a restrictive cardiomyopathy linked cardiac troponin I mutation (R145W) in transgenic mice. J Mol Biol 2009 Jul 31.
136. Kruger M., Zittrich S., Redwood C., Blaudeck N., James J., Robbins J., et al. Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils. J Physiol 2005 Apr 15, 564(Pt 2):347-357.
137. Knollmann B.C., Blatt S.A., Horton K., de Freitas F., Miller T., Bell M., et al. Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy. J Biol Chem 2001 Mar 30, 276(13):10039-10048.
138. Knollmann B.C., Potter J.D. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. Trends Cardiovasc Med 2001, 11(5):206-212.
139. Sirenko S.G., Potter J.D., Knollmann B.C. Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts-role of myofilament Ca2+ sensitivity increase. J Physiol (Lond) 2006 August 15, 575(1):201-213.
140. de Tombe P.P. Altered contractile function in heart failure. Cardiovasc Res 1998, 37:367-380.
141. Grossman W. Diastolic dysfunction in congestive heart failure. N Engl J Med 1991, 325:1557-1564.
142. Alpert N.R., Gordon M.S. Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am J Physiol 1962 May, 202:940-946.
143. Perez N.G., Hashimoto K., McCune S., Altschuld R.A., Marban E. Origin of contractile dysfunction in heart failure: calcium cycling versus myofilaments. Circulation 1999 Mar 2, 99(8):1077-1083.
144. Knollmann B.C., Kirchhof P., Sirenko S.G., Degen H., Greene A.E., Schober T., et al. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling. Circ Res 2003 Mar 7, 92(4):428-436.
145. Baudenbacher F., Schober T., Pinto J.R., Sidorov V.Y., Hilliard F., Solaro R.J., et al. Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest 2008 Dec, 118(12):3893-3903.
146. Ashrafian H., Redwood C., Blair E., Watkins H. Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion. Trends Genet 2003 May, 19(5):263-268.
147. Alcalai R., Seidman J.G., Seidman C.E. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol 2008 Jan, 19(1):104-110.
148. Fatkin D., Graham R.M. Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 2002, 82:945-980.
149. Varnava A.M., Elliott P.M., Baboonian C., Davison F., Davies M.J., McKenna W.J. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 2001 Sep 18, 104(12):1380-1384.
150. Genomics of cardiovascular development A, and remodeling: NHLBI Program for Genomic Applications, Beth Israel Deaconess Medical Center Available at, 2009 Oct. http://www.cardiogenomics.org.
151. Richard P., Charron P., Carrier L., Ledeuil C., Cheav T., Pichereau C., et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003 May 6, 107(17):2227-2232.
152. Niimura H., Patton K.K., McKenna W.J., Soults J., Maron B.J., Seidman J.G., et al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 2002 Jan 29, 105(4):446-451.
153. Sheng H.Z., Shan Q.J., Wu X., Cao K.J. Cardiac troponin I gene mutation (Asp127Tyr) in a Chinese patient with hypertrophic cardiomyopathy. Zhonghua Xin Xue Guan Bing Za Zhi 2008 Dec, 36(12):1063-1065.
154. Watkins H., McKenna W.J., Thierfelder L., Suk H.J., Anan R., O'Donoghue A., et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995 Apr 20, 332(16):1058-1064.
155. Mogensen J., Bahl A., Kubo T., Elanko N., Taylor R., McKenna W.J. Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy. J Med Genet 2003 May, 40(5):e59.
156. Konno T., Shimizu M., Ino H., Fujino N., Hayashi K., Uchiyama K., et al. Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects. J Intern Med 2005 Sep, 258(3):216-224.
157. Kimura A., Harada H., Park J.E., Nishi H., Satoh M., Takahashi M., et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997 Aug, 16(4):379-382.
158. Van Driest S.L., Ellsworth E.G., Ommen S.R., Tajik A.J., Gersh B.J., Ackerman M.J. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 2003 Jul 29, 108(4):445-451.
159. Koga Y., Toshima H., Kimura A., Harada H., Koyanagi T., Nishi H., et al. Clinical manifestations of hypertrophic cardiomyopathy with mutations in the cardiac beta-myosin heavy chain gene or cardiac troponin T gene. J Card Fail 1996 Dec, 2(4 Suppl):S97-103.
160. Forissier J.F., Carrier L., Farza H., Bonne G., Bercovici J., Richard P., et al. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 1996 Dec 15, 94(12):3069-3073.
161. Cheng T.O. Frequency of cardiac troponin I mutations in families with hypertrophic cardiomyopathy in China. J Am Coll Cardiol 2005 Jul 5, 46(1):180-181. author reply 1.
162. Ingles J., Doolan A., Chiu C., Seidman J., Seidman C., Semsarian C. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet 2005 Oct, 42(10):e59.
163. Doolan A., Tebo M., Ingles J., Nguyen L., Tsoutsman T., Lam L., et al. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences. J Mol Cell Cardiol 2005 Feb, 38(2):387-393.
164. Varnava A., Baboonian C., Davison F., de Cruz L., Elliott P.M., Davies M.J., et al. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart 1999 Nov, 82(5):621-624.
165. D'Cruz L.G., Baboonian C., Phillimore H.E., Taylor R., Elliott P.M., Varnava A., et al. Cytosine methylation confers instability on the cardiac troponin T gene in hypertrophic cardiomyopathy. J Med Genet 2000 Sep, 37(9):E18.
166. Van Driest S.L., Vasile V.C., Ommen S.R., Will M.L., Tajik A.J., Gersh B.J., et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004 Nov 2, 44(9):1903-1910.
167. Nakajima-Taniguchi C., Matsui H., Fujio Y., Nagata S., Kishimoto T., Yamauchi-Takihara K. Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy. J Mol Cell Cardiol 1997 Feb, 29(2):839-843.
168. Anan R., Shono H., Kisanuki A., Arima S., Nakao S., Tanaka H. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation 1998 Aug 4, 98(5):391-397.
169. Torricelli F., Girolami F., Olivotto I., Passerini I., Frusconi S., Vargiu D., et al. Prevalence and clinical profile of troponin T mutations among patients with hypertrophic cardiomyopathy in tuscany. Am J Cardiol 2003 Dec 1, 92(11):1358-1362.
170. An F.S., Zhang Y., Li D.Q., Yang X.S., Li L., Zhang C., et al. A novel missense mutation, K124N, in the troponin T gene of Chinese populations with hypertrophic cardiomyopathy. Zhonghua Yi Xue Za Zhi 2004 Aug 17, 84(16):1340-1343.
171. Ho C.Y., Lever H.M., DeSanctis R., Farver C.F., Seidman J.G., Seidman C.E. Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy. Circulation 2000 Oct 17, 102(16):1950-1955.
172. Garcia-Castro M., Reguero J.R., Batalla A., Diaz-Molina B., Gonzalez P., Alvarez V., et al. Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients. Clin Chem 2003 Aug, 49(8):1279-1285.
173. Morner S., Richard P., Kazzam E., Hellman U., Hainque B., Schwartz K., et al. Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. J Mol Cell Cardiol 2003 Jul, 35(7):841-849.
174. Fujino N., Shimizu M., Ino H., Yamaguchi M., Yasuda T., Nagata M., et al. A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy. Am J Cardiol 2002 Jan 1, 89(1):29-33.
175. Elliott P.M., D'Cruz L., McKenna W.J. Late-onset hypertrophic cardiomyopathy caused by a mutation in the cardiac troponin T gene. N Engl J Med 1999 Dec 9, 341(24):1855-1856.
176. Erdmann F.J., Wischke S., Riedel K., Kallisch H., Fleck M.E., Regitz-Zagrosek F.V. A new mutation (Arg-278-Pro) in the cardiac troponin T gene (TNNT2) was identified in one patient with typical hypertrophic cardiomyopathy (HCM). Circulation 1998, 98(1273):1998.
177. Murphy R.T., Mogensen J., Shaw A., Kubo T., Hughes S., McKenna W.J. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet 2004 Jan 31, 363(9406):371-372.
178. Miliou A., Anastasakis A., D'Cruz L.G., Theopistou A., Rigopoulos A., Rizos I., et al. Low prevalence of cardiac troponin T mutations in a Greek hypertrophic cardiomyopathy cohort. Heart 2005 Jul, 91(7):966-967.
179. Mogensen J., Murphy R.T., Shaw T., Bahl A., Redwood C., Watkins H., et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004 Nov 16, 44(10):2033-2040.
180. Hershberger R.C., Parks S.B., Kushner J.D., Li D., Ludwigsen S., Jakobs P., et al. Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clinical and Translational Science 2008, 1(1):21-26.
181. Kostareva A., Gudkova A., Sjoberg G., Morner S., Semernin E., Krutikov A., et al. Deletion in TNNI3 gene is associated with restrictive cardiomyopathy. Int J Cardiol 2009 Jan 24, 131(3):410-412.
182. Stefanelli C.B., Rosenthal A., Borisov A.B., Ensing G.J. Russell MW. Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity. Mol Genet Metab 2004 Sep-Oct, 83(1-2):188-196.
183. Van Acker H, De Sutter J, Vandekerckhove K, de Ravel TJ, Verhaaren H, De Backer J. Dilated cardiomyopathy caused by a novel TNNT2 mutation-Added value of genetic testing in the correct identification of affected subjects. Int J Cardiol 2009 Mar 25.
184. Hanson EL, Jakobs PM, Keegan H, Coates K, Bousman S, Dienel NH, et al. Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy. J Card Fail 2002 Feb;8(1):28-32.
185. Peddy SB, Vricella LA, Crosson JE, Oswald GL, Cohn RD, Cameron DE, et al. Infantile restrictive cardiomyopathy resulting from a mutation in the cardiactroponin T gene. Pediatrics 2006 May;117(5):1830-3.